Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Never settle: How Jimmy's story with GPP inspires greater action and support

(BPT) - Jimmy Castillo has always welcomed new adventures. The Southern California native enjoys traveling and exploring new corners of the world. But after decades of global exploration, his most unexpected journey began close to home - in his doctor's office.

At age 39, Castillo started noticing patches of painful, pus-filled blisters across his body, including his hands and lower back. Though he had been diagnosed with plaque psoriasis decades earlier at age 15, he knew immediately that this was something different.

"It was different than what I was used to as a teenager," he recalls. "I knew something wasn't right."

Unbeknownst to Castillo, he was grappling with generalized pustular psoriasis (GPP) - a potentially dangerous and distinct form of psoriasis. GPP occurs when there is an imbalance in one of the pathways that manages inflammation in your body - the interleukin-36, or IL-36 pathway.

GPP is characterized by the sudden appearance of multiple small blisters filled with pus (called pustules) on large areas of the skin of the body, arms, and legs, that also become red and painful. Intense symptoms can include fever, chills and loss of appetite. GPP can cause underlying inflammation, plus unpredictable flares which can occur several times a year and can become life-threatening. GPP is rare, impacting approximately 1 in 10,000 people in the United States.

Jimmy leans against a barrier at a boardwalk.


While GPP can develop at any age, most people are diagnosed in their 50s, and it is more common in women. The physical and emotional toll can be substantial - impacting daily activities, triggering anxiety, and leaving many in fear of their next flare.

"It was in very noticeable areas," Castillo shares. "Having it on my hands and using my hands to pay or to eat - I felt like everybody noticed. I became very shy, and I didn't want to go out, I used to wear gloves with fingertips cut out just to feel a little more comfortable."

Refusing to settle, he fought for a diagnosis and began learning more about his GPP. While flare-ups still occur, he now feels empowered with the knowledge and tools to navigate them.

A turning point came when he connected with others in the GPP community. "With GPP, you live in fear every day," Castillo says. "Talking to peers, participating in events, and learning from others with GPP has made a world of difference. I realized I wasn't alone."

Jimmy poses in the center of a wooden bridge in the woods.


"Jimmy's experience highlights the critical need for increased awareness of generalized pustular psoriasis (GPP), a chronic and rare disease that can leave individuals feeling isolated and misunderstood. By equipping those impacted by GPP with education and a sense of community, we can work to overcome diagnostic delays and alleviate daily challenges, creating a future where no one faces GPP alone," said Vicky Brown, Senior Vice President, U.S. Therapeutic Head for Immunology, Oncology & Eye Health, Boehringer Ingelheim Pharmaceuticals, Inc.

For too long, patients with GPP have felt resigned to managing symptoms alone, but that landscape is changing. Jimmy's story is a powerful reminder that patients deserve more than "good enough" care - they deserve to live openly without fear.

Boehringer Ingelheim is proud to sponsor the National Psoriasis Foundation's first-ever GPP Awareness Day on August 13, reinforcing its commitment to raising awareness and supporting the GPP community through education, advocacy, and connection.

GPP and plaque psoriasis are different, so it's important to speak with your dermatologist or other health care provider to get an accurate diagnosis and to help ensure the best care.

To learn more about GPP and to hear from others in the community, visit GPPandMe.com.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.